Monika Bullinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Monika Bullinger has a total of 523 co-authors. Here are the top co-authors by number of shared publications:
- Julia Quitmann
Institute and Polyclinic for Medical Psychology University Medical Center Hamburg‐Eppendorf Hamburg Germany
15 shared publications - Neuza Silva
German Center for Health Services Research in Dermatology (CVderm), Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
8 shared publications - Stefanie Witt
Institute and Polyclinic for Medical Psychology University Medical Center Hamburg‐Eppendorf Hamburg Germany
7 shared publications Julia Quitmann
A Department of Medical Psychology , Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf , Hamburg , Germany
6 shared publications- Rachel Sommer
Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen Universitätsklinikum Hamburg‐Eppendorf, Hamburg
6 shared publications - Ulrike Ravens-Sieberer
Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
6 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Enfermagem
- Vol. 78 (4)
Adaptação cultural para o Brasil do Child Abuse and Neglect Reporting Self-Efficacy Questionnaire
RESUMO Objetivos: adaptar culturalmente o Child Abuse and Neglect Reporting Self-Efficacy Questionnaire para o Brasil. Métodos: estudo metodológico de aplicação clínica, envolvendo 126 profissionais de saúde, desenvolvido entre 2022 e 2023. O instrumento mensura a autoeficácia dos profissionais de saúde para a notificação de casos de abuso e negligência infantil. O processo de tradução para a língua portuguesa, falada e escrita no Brasil, e retrotradução seguiu padrões internacionais, e a validade de face foi implementada usando método internacional. Resultados: a versão brasileira está composta por duas dimensões e 35 itens, sendo bem avaliada pelos participantes, com a maioria o considerando bom ou muito bom (88,1%), com questões fáceis de entender (73,8%), sem qualquer dificuldade com as opções das respostas (74,6%) e muito importantes para a situação (85,7%). Conclusões: a versão traduzida preservou equivalência conceitual dos itens, apresentando validade de face, e pode ser considerada adaptada culturalmente para o contexto estudado.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Enfermagem
- Vol. 78 (4)
Open AccessAdaptação cultural para o Brasil do Child Abuse and Neglect Reporting Self-Efficacy Questionnaire
RESUMO Objetivos: adaptar culturalmente o Child Abuse and Neglect Reporting Self-Efficacy Questionnaire para o Brasil. Métodos: estudo metodológico de aplicação clínica, envolvendo 126 profissionais de saúde, desenvolvido entre 2022 e 2023. O instrumento mensura a autoeficácia dos profissionais de saúde para a notificação de casos de abuso e negligência infantil. O processo de tradução para a língua portuguesa, falada e escrita no Brasil, e retrotradução seguiu padrões internacionais, e a validade de face foi implementada usando método internacional. Resultados: a versão brasileira está composta por duas dimensões e 35 itens, sendo bem avaliada pelos participantes, com a maioria o considerando bom ou muito bom (88,1%), com questões fáceis de entender (73,8%), sem qualquer dificuldade com as opções das respostas (74,6%) e muito importantes para a situação (85,7%). Conclusões: a versão traduzida preservou equivalência conceitual dos itens, apresentando validade de face, e pode ser considerada adaptada culturalmente para o contexto estudado.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Enfermagem
- Vol. 78 (4) , e20240220
Cultural adaptation for Brazil of the Child Abuse and Neglect Reporting Self-Efficacy Questionnaire
Objectives: to culturally adapt the Child Abuse and Neglect Reporting Self-Efficacy Questionnaire for Brazil. Methods: a methodological study of clinical application, involving 126 healthcare professionals, developed between 2022 and 2023. The instrument measures healthcare professionals’ self-efficacy in reporting cases of child abuse and neglect. The translation process into Brazilian Portuguese and back-translation followed international standards, and face validity was implemented using an international method. Results: the Brazilian version is composed of two dimensions and 35 items, and was well assessed by participants, with the majority considering it good or very good (88.1%), with easy-to-understand questions (73.8%), without any difficulty with the answer options (74.6%) and very important for the situation (85.7%). Conclusions: the translated version preserved the conceptual equivalence of items, presenting face validity, and can be considered culturally adapted to the context studied.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Enfermagem
- Vol. 78 (4) , e20240220
Open AccessCultural adaptation for Brazil of the Child Abuse and Neglect Reporting Self-Efficacy Questionnaire
Objectives: to culturally adapt the Child Abuse and Neglect Reporting Self-Efficacy Questionnaire for Brazil. Methods: a methodological study of clinical application, involving 126 healthcare professionals, developed between 2022 and 2023. The instrument measures healthcare professionals’ self-efficacy in reporting cases of child abuse and neglect. The translation process into Brazilian Portuguese and back-translation followed international standards, and face validity was implemented using an international method. Results: the Brazilian version is composed of two dimensions and 35 items, and was well assessed by participants, with the majority considering it good or very good (88.1%), with easy-to-understand questions (73.8%), without any difficulty with the answer options (74.6%) and very important for the situation (85.7%). Conclusions: the translated version preserved the conceptual equivalence of items, presenting face validity, and can be considered culturally adapted to the context studied.
- 1 March 2024
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 37 (4) , 326-335
Growth hormone treatment in children with short stature: impact of the diagnosis on parents
Objectives: This prospective multicenter study aimed (1) to examine changes in parent-reported health-related quality of life (HRQOL) of children with short stature and the effects of the children’s condition on parents themselves within the first year of human growth hormone (hGH) treatment and (2) to predict effects on parents based on main and interaction effects of children’s HRQOL and increase in height. Methods: A total of 110 parents of children aged 4–18 years, diagnosed with idiopathic growth hormone deficiency, small for gestational age, or idiopathic short stature, were recruited from 11 participating German pediatric endocrinologists and asked to fill out the short stature-specific Quality of Life in Short Stature Youth (QoLISSY) Questionnaire before hGH treatment was initiated and one year later. Results: Negative effects of the children’s short stature on the parents decrease over time, independent of diagnosis and treatment status. Furthermore, treatment status and height increase moderated the links between children’s improved HRQOL as perceived by their parents and decreased caregiving burden. Conclusions: Based on the children’s improved HRQOL and the parent’s decrease in caregiving burden, patient-reported outcomes that consider parental and child’s perspectives should be considered when deciding on hGH treatment for children.
- 1 March 2024
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 37 (4) , 326-335
Growth hormone treatment in children with short stature: impact of the diagnosis on parents
Objectives: This prospective multicenter study aimed (1) to examine changes in parent-reported health-related quality of life (HRQOL) of children with short stature and the effects of the children’s condition on parents themselves within the first year of human growth hormone (hGH) treatment and (2) to predict effects on parents based on main and interaction effects of children’s HRQOL and increase in height. Methods: A total of 110 parents of children aged 4–18 years, diagnosed with idiopathic growth hormone deficiency, small for gestational age, or idiopathic short stature, were recruited from 11 participating German pediatric endocrinologists and asked to fill out the short stature-specific Quality of Life in Short Stature Youth (QoLISSY) Questionnaire before hGH treatment was initiated and one year later. Results: Negative effects of the children’s short stature on the parents decrease over time, independent of diagnosis and treatment status. Furthermore, treatment status and height increase moderated the links between children’s improved HRQOL as perceived by their parents and decreased caregiving burden. Conclusions: Based on the children’s improved HRQOL and the parent’s decrease in caregiving burden, patient-reported outcomes that consider parental and child’s perspectives should be considered when deciding on hGH treatment for children.
- Open Access
- 1 July 2022
- Published by Taylor & Francis in Patient Related Outcome Measures
- Vol. ume 13, 169-180
Psychometric Validation of the Haemo-QOL-A in Participants with Hemophilia A Treated with Gene Therapy
Purpose: The hemophilia-specific health-related quality of life (HRQOL) questionnaire (Haemo-QOL-A) is validated for detecting QOL changes following standard therapy for hemophilia A, but has not been rigorously evaluated after gene therapy. This post hoc analysis evaluated the psychometric properties of Haemo-QOL-A in adult people with severe hemophilia A (PWSHA) receiving valoctocogene roxaparvovec (AAV5-hFVIII-SQ) in 2 clinical trials (phase 1/2, NCT02576795; phase 3, NCT03370913). Patients and Methods: Adult PWSHA (factor VIII levels ≤ 1 IU/dL) received 1 AAV5-hFVIII-SQ infusion (6× 1013 vg/kg). Participants were assessed using the Haemo-QOL-A and the EuroQOL (EQ)-5D-5L and visual analog scale (VAS) questionnaires pre- and post-infusion. Psychometric analyses included convergent and discriminant validity, internal consistency, and reliability. Clinically important difference (CID) was estimated using 3-point change in EQ-5D-5L VAS as anchor. Results: Haemo-QOL-A data were analyzed from 7 (phase 1/2, 3-year follow-up) and 16 participants (phase 3, 26-week analysis). Change in Haemo-QOL-A Total Scores correlated with EQ-5D-5L VAS score change at 26 weeks (Pearson’s correlation 0.77). At 26 weeks, increased Haemo-QOL-A Physical Functioning was associated with decreased EQ-5D-5L Pain and Discomfort and decreased Anxiety and Depression (Spearman’s Rank correlations − 0.73 and − 0.62, respectively, P < 0.01). Internal consistency analysis showed good reliability for all domains (Cronbach’s alpha > 0.7) except Treatment Concern (Cronbach’s alpha = 0.31). Anchor-based CID estimates were met for Haemo-QOL-A Total Score (≥ 5.5) and domain scores (≥ 6) for Consequences of Bleeding, Physical Functioning, Role Functioning, and Worry. Conclusion: Our preliminary results suggest that the Haemo‐QOL‐A is a valid, reliable instrument for HRQOL assessment in PWSHA undergoing gene therapy. Future research should be undertaken to confirm these findings in a larger number of participants.
- 1 July 2022
- Published by Taylor & Francis in Patient Related Outcome Measures
- Vol. ume 13, 169-180
Open AccessPsychometric Validation of the Haemo-QOL-A in Participants with Hemophilia A Treated with Gene Therapy
Purpose: The hemophilia-specific health-related quality of life (HRQOL) questionnaire (Haemo-QOL-A) is validated for detecting QOL changes following standard therapy for hemophilia A, but has not been rigorously evaluated after gene therapy. This post hoc analysis evaluated the psychometric properties of Haemo-QOL-A in adult people with severe hemophilia A (PWSHA) receiving valoctocogene roxaparvovec (AAV5-hFVIII-SQ) in 2 clinical trials (phase 1/2, NCT02576795; phase 3, NCT03370913). Patients and Methods: Adult PWSHA (factor VIII levels ≤ 1 IU/dL) received 1 AAV5-hFVIII-SQ infusion (6× 1013 vg/kg). Participants were assessed using the Haemo-QOL-A and the EuroQOL (EQ)-5D-5L and visual analog scale (VAS) questionnaires pre- and post-infusion. Psychometric analyses included convergent and discriminant validity, internal consistency, and reliability. Clinically important difference (CID) was estimated using 3-point change in EQ-5D-5L VAS as anchor. Results: Haemo-QOL-A data were analyzed from 7 (phase 1/2, 3-year follow-up) and 16 participants (phase 3, 26-week analysis). Change in Haemo-QOL-A Total Scores correlated with EQ-5D-5L VAS score change at 26 weeks (Pearson’s correlation 0.77). At 26 weeks, increased Haemo-QOL-A Physical Functioning was associated with decreased EQ-5D-5L Pain and Discomfort and decreased Anxiety and Depression (Spearman’s Rank correlations − 0.73 and − 0.62, respectively, P < 0.01). Internal consistency analysis showed good reliability for all domains (Cronbach’s alpha > 0.7) except Treatment Concern (Cronbach’s alpha = 0.31). Anchor-based CID estimates were met for Haemo-QOL-A Total Score (≥ 5.5) and domain scores (≥ 6) for Consequences of Bleeding, Physical Functioning, Role Functioning, and Worry. Conclusion: Our preliminary results suggest that the Haemo‐QOL‐A is a valid, reliable instrument for HRQOL assessment in PWSHA undergoing gene therapy. Future research should be undertaken to confirm these findings in a larger number of participants.
- 5 May 2022
- Published by Springer Nature in Journal of Clinical Psychology in Medical Settings
- Vol. 29 (2) , 466-475
Quality of Life of Children and Adolescents with Short Stature: The Twofold Contribution of Physical Growth and Adaptive Height-Related Cognitive Beliefs
This study aimed to examine the health-related quality of life (HrQoL), coping, height-related beliefs, and social support of children/adolescents with short stature, the sociodemographic, clinical, and psychosocial variables associated with HrQoL, and the moderating role of sociodemographic and clinical variables on the associations between psychosocial variables and HrQoL. 114 Portuguese children/adolescents with short stature, aged 8–18 years old, completed the Quality of Life in Short Stature Youth questionnaire and the Satisfaction with Social Support Scale. Regression analyses explained 54% of the variance of HrQoL, with significant main effects of current height deviation and height-related beliefs, and a significant interaction effect between beliefs and diagnosis. Results suggest that a multidisciplinary therapeutic approach, not only focused on hormone treatment to boost physical growth, but also including psychosocial interventions focused on the modification of height-related beliefs, may contribute to improve the HrQoL of pediatric patients with short stature.
- 5 May 2022
- Published by Springer Nature in Journal of Clinical Psychology in Medical Settings
- Vol. 29 (2) , 466-475
Quality of Life of Children and Adolescents with Short Stature: The Twofold Contribution of Physical Growth and Adaptive Height-Related Cognitive Beliefs
This study aimed to examine the health-related quality of life (HrQoL), coping, height-related beliefs, and social support of children/adolescents with short stature, the sociodemographic, clinical, and psychosocial variables associated with HrQoL, and the moderating role of sociodemographic and clinical variables on the associations between psychosocial variables and HrQoL. 114 Portuguese children/adolescents with short stature, aged 8–18 years old, completed the Quality of Life in Short Stature Youth questionnaire and the Satisfaction with Social Support Scale. Regression analyses explained 54% of the variance of HrQoL, with significant main effects of current height deviation and height-related beliefs, and a significant interaction effect between beliefs and diagnosis. Results suggest that a multidisciplinary therapeutic approach, not only focused on hormone treatment to boost physical growth, but also including psychosocial interventions focused on the modification of height-related beliefs, may contribute to improve the HrQoL of pediatric patients with short stature.
- Open Access
- 1 January 2021
- Published by Haemnet Ltd in The Journal of Haemophilia Practice
- Vol. 8 (1) , 56-68
The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia
Introduction: Haemophilia is an inherited bleeding disorder characterised by spontaneous bleeding, often leading to impaired health-related quality of life (HRQoL). Commonly used treatments include episodic and prophylactic treatment regimens. Gene therapies could soon become available, potentially creating a paradigm shift in patient management. Aim: This paper proposes hypotheses about the potential impact of gene therapy on HRQoL domains in haemophilia, and how these impacts might differ compared with existing treatments. Methods: An expert working group with 10 individuals experienced in haemophilia and HRQoL research was established to discuss potential impacts of gene therapy on HRQoL in general and for specific domains in haemophilia. As part of a one-day workshop, domains of three widely used patient-reported outcome (PRO) instruments were explored: the Haemo-QoL-A, the Patient Reported Outcomes, Burden and Experiences (PROBE), and the Haemophilia Activities List (HAL). Results: The group expected a greater improvement in HRQoL from gene therapy compared with existing treatments for the following domains: physical/role functioning, worry, and consequences of bleeding (Haemo-QoL-A); haemophilia-related health and EQ-5D-5L (part of the PROBE); leg and arm function, and leisure activities (HAL). In contrast, the experts suggested that no change or potential deterioration might be observed for the emotional impact (HAL) and treatment concerns (Haemo-QoL-A) domains. Conclusions: Current PRO instruments in haemophilia have limitations when applied in the context of gene therapy, and no single instrument fully captures the relevant HRQoL domains. However, the PROBE and Haemo-QoL-A were considered as the most suitable existing instruments. As haemophilia treatments evolve, further research should examine the potential effectiveness of existing PRO instruments as compared to the development of novel PRO measures.
- 1 January 2021
- Published by Haemnet Ltd in The Journal of Haemophilia Practice
- Vol. 8 (1) , 56-68
Open AccessThe potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia
Introduction: Haemophilia is an inherited bleeding disorder characterised by spontaneous bleeding, often leading to impaired health-related quality of life (HRQoL). Commonly used treatments include episodic and prophylactic treatment regimens. Gene therapies could soon become available, potentially creating a paradigm shift in patient management. Aim: This paper proposes hypotheses about the potential impact of gene therapy on HRQoL domains in haemophilia, and how these impacts might differ compared with existing treatments. Methods: An expert working group with 10 individuals experienced in haemophilia and HRQoL research was established to discuss potential impacts of gene therapy on HRQoL in general and for specific domains in haemophilia. As part of a one-day workshop, domains of three widely used patient-reported outcome (PRO) instruments were explored: the Haemo-QoL-A, the Patient Reported Outcomes, Burden and Experiences (PROBE), and the Haemophilia Activities List (HAL). Results: The group expected a greater improvement in HRQoL from gene therapy compared with existing treatments for the following domains: physical/role functioning, worry, and consequences of bleeding (Haemo-QoL-A); haemophilia-related health and EQ-5D-5L (part of the PROBE); leg and arm function, and leisure activities (HAL). In contrast, the experts suggested that no change or potential deterioration might be observed for the emotional impact (HAL) and treatment concerns (Haemo-QoL-A) domains. Conclusions: Current PRO instruments in haemophilia have limitations when applied in the context of gene therapy, and no single instrument fully captures the relevant HRQoL domains. However, the PROBE and Haemo-QoL-A were considered as the most suitable existing instruments. As haemophilia treatments evolve, further research should examine the potential effectiveness of existing PRO instruments as compared to the development of novel PRO measures.
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Revista Latino-Americana de Enfermagem
- Vol. 28, e3257
DISABKIDS® in Brazil: advances and future perspectives for the production of scientific knowledge
Objective: to map the Brazilian scientific production related to the stages of the methodological process for the use of DISABKIDS® instruments and/or forms adapted to Brazil. Method: scoping review, with searches conducted on10 electronic databases, plus Google Scholar and contacts with researchers, without restriction of period or language. Results: the mapping identified 90 scientific studies involving 46 instruments. Of these, 11 (23.9%) included the elaboration and/or cultural adaptation of the DISABKIDS® instruments to measure the Quality of Life of children or adolescents with chronic conditions and 35 (76.1%) used the Generic Measures and/or Specific Modules for the semantic validation of other instruments. Conclusion: this scoping review allowed a comprehensive evaluation of the use of the DISABKIDS® instrument and forms, in relation to the validation of the instrument adapted to Brazil, presenting a positive advance in the scenario with the development of academic/scientific projects in the country, incorporating the method recommended by the literature for the elaboration, cultural adaptation and validation of instruments and for the systematized and standardized recording of the perception and understanding of the target population about the measure of interest, using DISABKIDS® forms adapted for this purpose.
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Revista Latino-Americana de Enfermagem
- Vol. 28, e3257
Open AccessDISABKIDS® in Brazil: advances and future perspectives for the production of scientific knowledge
Objective: to map the Brazilian scientific production related to the stages of the methodological process for the use of DISABKIDS® instruments and/or forms adapted to Brazil. Method: scoping review, with searches conducted on10 electronic databases, plus Google Scholar and contacts with researchers, without restriction of period or language. Results: the mapping identified 90 scientific studies involving 46 instruments. Of these, 11 (23.9%) included the elaboration and/or cultural adaptation of the DISABKIDS® instruments to measure the Quality of Life of children or adolescents with chronic conditions and 35 (76.1%) used the Generic Measures and/or Specific Modules for the semantic validation of other instruments. Conclusion: this scoping review allowed a comprehensive evaluation of the use of the DISABKIDS® instrument and forms, in relation to the validation of the instrument adapted to Brazil, presenting a positive advance in the scenario with the development of academic/scientific projects in the country, incorporating the method recommended by the literature for the elaboration, cultural adaptation and validation of instruments and for the systematized and standardized recording of the perception and understanding of the target population about the measure of interest, using DISABKIDS® forms adapted for this purpose.
- Open Access
- 11 September 2019
- Published by Springer Nature in BMC Pediatrics
- Vol. 19 (1) , 1-9
Agreement between mothers’, fathers’, and children’s’ ratings on health-related quality of life in children born with esophageal atresia – a German cross-sectional study
Background: Esophageal atresia (EA) is a rare congenital malformation, which is characterized by the discontinuity of the esophagus. We investigated the agreement between mothers’, fathers’, and children’s’ ratings on health-related quality of life (HRQOL) in children born with EA. We aimed to broaden the understanding of subjective experiences of HRQOL from different perspectives. We hypothesized that the agreement between mother and father ratings would be high, whereas the agreement between child and mother ratings as well as child and father ratings would show more substantial differences.Methods: We obtained data from 40 families (23 mother-father dyads of children aged 2–7 years and 17 mother-father-child triads of children and adolescents aged 8–18 years) with children born with EA, who were treated in two German hospitals. HRQOL was measured using the generic PedsQL™ questionnaires and the condition-specific EA-QOL© questionnaires. We calculated intraclass coefficients and performed one-way repeated measures ANOVAs to analyze differences for each domain as well as for the total scores.Results: Intraclass correlation coefficients (ICCs) indicated a strong agreement (≥.80) between mother and father reports of children’s HRQOL for both generic and condition-specific measurements. The ICCs for the generic HRQOL for mother/father-child-dyads revealed only fair to good agreement, whereas ICCs for condition-specific HRQOL showed high agreement for mother-child and father-child-agreement. Analyses of Covariance revealed differences in mother/father-child agreement in the generic domain School, both parents reporting lower HRQOL scores than the children themselves. Fathers reported significantly higher scores in the condition-specific domain Social than their children.Conclusions: Results showed that mothers’ and fathers’ reports corresponded to each other. Nonetheless, these reports might not be interchangeably used because mother-child and father-child agreement showed differences. Children might know the best on how they feel, and parent proxy-report is recommended when reasons such as young age, illness, or cognitive impairments do not allow to ask the child. But parent-report – no matter if reported by mother or father – should only be an additional source to broaden the view on the child’s health status and well-being. The current study contributes to a better understanding of the complex family relationships involved when parenting a child born with EA.
- 11 September 2019
- Published by Springer Nature in BMC Pediatrics
- Vol. 19 (1) , 1-9
Open AccessAgreement between mothers’, fathers’, and children’s’ ratings on health-related quality of life in children born with esophageal atresia – a German cross-sectional study
Background: Esophageal atresia (EA) is a rare congenital malformation, which is characterized by the discontinuity of the esophagus. We investigated the agreement between mothers’, fathers’, and children’s’ ratings on health-related quality of life (HRQOL) in children born with EA. We aimed to broaden the understanding of subjective experiences of HRQOL from different perspectives. We hypothesized that the agreement between mother and father ratings would be high, whereas the agreement between child and mother ratings as well as child and father ratings would show more substantial differences.Methods: We obtained data from 40 families (23 mother-father dyads of children aged 2–7 years and 17 mother-father-child triads of children and adolescents aged 8–18 years) with children born with EA, who were treated in two German hospitals. HRQOL was measured using the generic PedsQL™ questionnaires and the condition-specific EA-QOL© questionnaires. We calculated intraclass coefficients and performed one-way repeated measures ANOVAs to analyze differences for each domain as well as for the total scores.Results: Intraclass correlation coefficients (ICCs) indicated a strong agreement (≥.80) between mother and father reports of children’s HRQOL for both generic and condition-specific measurements. The ICCs for the generic HRQOL for mother/father-child-dyads revealed only fair to good agreement, whereas ICCs for condition-specific HRQOL showed high agreement for mother-child and father-child-agreement. Analyses of Covariance revealed differences in mother/father-child agreement in the generic domain School, both parents reporting lower HRQOL scores than the children themselves. Fathers reported significantly higher scores in the condition-specific domain Social than their children.Conclusions: Results showed that mothers’ and fathers’ reports corresponded to each other. Nonetheless, these reports might not be interchangeably used because mother-child and father-child agreement showed differences. Children might know the best on how they feel, and parent proxy-report is recommended when reasons such as young age, illness, or cognitive impairments do not allow to ask the child. But parent-report – no matter if reported by mother or father – should only be an additional source to broaden the view on the child’s health status and well-being. The current study contributes to a better understanding of the complex family relationships involved when parenting a child born with EA.
- 1 September 2019
- Published by Elsevier in Public Health
- Vol. 174, 134-144
Subjective integration and quality of life of Sub-Saharan African migrants in Germany
- 1 September 2019
- Published by Elsevier in Public Health
- Vol. 174, 134-144
Subjective integration and quality of life of Sub-Saharan African migrants in Germany
- Open Access
- 9 August 2019
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 14 (1) , 1-9
Quality of life of children with achondroplasia and their parents - a German cross-sectional study
Achondroplasia is the most common form of disproportionate short stature and might affect not only the quality of life of the affected child but also that of the parents. We aimed to investigate the quality of life of children with achondroplasia from child- and parent perspective as well as the parental quality of life. Forty-seven children with achondroplasia and 73 parents from a German patient organization participated. We assessed children’s quality of life using the generic Peds QL 4.0™ as self-reports for children aged 8–14 and parent-reports for children aged 4–14 years. Parental quality of life we assessed using the short-form 8-questionnaire. Children with achondroplasia showed significantly lower quality of life scores compared to a healthy reference population from both the child- and parent-report (p = ≤.01), except the child-report of the emotional domain (t (46) = − 1.73, p = .09). Parents reported significantly lower mental health in comparison with a German reference population (t (72) = 5.64, p ≤ .01) but no lower physical health (t (72) = .20, p = .85). While the parental quality of life was a significant predictor of parent-reported children’s quality of life (F (6,66) = 2.80, p = .02), it was not for child-reported children’s quality of life (F (6,66) = .92, p = .49). Achondroplasia is chronically debilitating. Thus special efforts are needed to address patients’ and parent’s quality of life needs. This special health condition may influence the daily life of the entire family because they have to adapt to the child’s particular needs. Therefore, clinicians should not only focus on the child’s quality of life but also those of the parents.
- 9 August 2019
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 14 (1) , 1-9
Open AccessQuality of life of children with achondroplasia and their parents - a German cross-sectional study
Achondroplasia is the most common form of disproportionate short stature and might affect not only the quality of life of the affected child but also that of the parents. We aimed to investigate the quality of life of children with achondroplasia from child- and parent perspective as well as the parental quality of life. Forty-seven children with achondroplasia and 73 parents from a German patient organization participated. We assessed children’s quality of life using the generic Peds QL 4.0™ as self-reports for children aged 8–14 and parent-reports for children aged 4–14 years. Parental quality of life we assessed using the short-form 8-questionnaire. Children with achondroplasia showed significantly lower quality of life scores compared to a healthy reference population from both the child- and parent-report (p = ≤.01), except the child-report of the emotional domain (t (46) = − 1.73, p = .09). Parents reported significantly lower mental health in comparison with a German reference population (t (72) = 5.64, p ≤ .01) but no lower physical health (t (72) = .20, p = .85). While the parental quality of life was a significant predictor of parent-reported children’s quality of life (F (6,66) = 2.80, p = .02), it was not for child-reported children’s quality of life (F (6,66) = .92, p = .49). Achondroplasia is chronically debilitating. Thus special efforts are needed to address patients’ and parent’s quality of life needs. This special health condition may influence the daily life of the entire family because they have to adapt to the child’s particular needs. Therefore, clinicians should not only focus on the child’s quality of life but also those of the parents.